NEONC TECHNOLOGIES HOLDINGS, INC.
Heshmatpour Amir F (CEO, President) purchased 50,000 shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at an average of $3.50 ($3.30–$3.96, $0.17M total) across 2 trades over 2026-09-14 to 2026-09-15.
CHEN THOMAS C (CEO) purchased 10,798 indirectly-held shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at an average of $3.70 ($3.60–$3.82) across 2 trades over 2026-09-11 to 2026-09-14.
GARNETT KEITHLY (CFO) purchased 257 shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $3.89 on 2026-09-14.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning NTHI (NEONC TECHNOLOGIES HOLDINGS, INC.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent NTHI coverage spans insider activity, corporate actions and financial news.
In the last 30 days, NTHI insiders filed 7 SEC Form 4 transactions — 6 purchases ($351K) and 1 sale ($17K). The most active reporter was Heshmatpour Amir F, CEO, President, with 3 filings. 14% of those filings were made under pre-arranged Rule 10b5-1 plans.
Insider buying by the CEO may signal confidence, but the transaction size is modest relative to market cap.
Insider purchase signals confidence but size is modest.
Minor insider purchase by CFO; unlikely to move price materially.
CEO buy indicates belief in upcoming milestones for the biotech.
Insider buy by the CEO may signal confidence and could provide modest upward pressure.
AlphAI scores every news story that mentions NTHI with an AI model for sentiment and relevance, and aggregates insider trades from NEONC TECHNOLOGIES HOLDINGS, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Heshmatpour Amir F (CEO, President) purchased 50,000 shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at an average of $3.50 ($3.30–$3.96, $0.17M total) across 2 trades over 2026-09-14 to 2026-09-15.
1 min readCHEN THOMAS C (CEO) purchased 10,798 indirectly-held shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at an average of $3.70 ($3.60–$3.82) across 2 trades over 2026-09-11 to 2026-09-14.
1 min readGARNETT KEITHLY (CFO) purchased 257 shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $3.89 on 2026-09-14.
1 min readOn September 14, 2026, insiders at PVH Corp. ($PVH), Hillman Solutions Corp. ($HLMN), Neonc Technologies Holdings, Inc. ($NTHI), Dominari Holdings Inc. ($DOMH), and Beeline Holdings, Inc. ($BLNE) made significant stock purchases. PVH's CEO bought 14,179 shares for $1M, Hillman's CFO bought 35,500 shares for $248.5K, Neonc's CEO bought 37,000 shares for $135.6K, Dominari's CEO bought 50,000 shares for $108.1K, and Beeline's CEO bought 93,200 shares for $94.2K.
2 min readHeshmatpour Amir F (CEO, President) purchased 37,000 shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $3.67 ($0.14M total) on 2026-09-11.
1 min readNEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors CALABASAS, Calif., September 9, 2026 – NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI)
1 min readCHEN THOMAS C (CEO) purchased 12,757 indirectly-held shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at $5.49 on 2026-08-18.
1 min readNEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. NeOnc Technologies Holdings, Inc. (the “Company”) held its 2026 annual meeting of stockholders on August 14, 2026 (the “Annual Meeting”) via live webcast. For more information about the proposals set forth below, ple
1 min readAmylyx Pharmaceuticals (AMLX) rose 55.71% after positive Phase 3 LUCIDITY trial results for Avexitide. AVITA Medical (RCEL) gained 21.90% on cost-effective PermeaDerm-I study data. CNS Pharmaceuticals (CNSP) increased 12.04% following a strategic financing and pipeline pivot. Orchestra BioMed (OBIO) advanced 15.04% with strategic capital and hypertension program progress. NeOnc Technologies (NTHI) climbed 13.80% on encouraging Phase 2a NEO100 data.
4 min readCHEN THOMAS C (CEO) purchased 36,259 shares of NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) at an average of $3.86 ($3.85–$4.04, $0.14M total) across 2 trades over 2026-08-14 to 2026-08-17.
2 min read
